Day 1 - EASL Congress 2024: Key Breakthroughs in the Treatment of Primary Biliary Cholangitis

Episode 1 -Podcast from EASL Congress 2024: Key Breakthroughs in the Treatment of Primary Biliary...Подробнее

Day 2 - EASL Congress 2024: Key Breakthroughs in the Treatment of Primary Biliary CholangitisПодробнее

Breaking analysis of ASSURE from EASL 2024 - Marc SwainПодробнее

The analysis of breakthrough research on Primary Biliary Cholangitis (PBC) with Kris KowdleyПодробнее

EASL Studio at EASL Congress 2024 - Advances in systemic treatments in liver cancerПодробнее

EASL Congress 2024 - Wrap up on Immune-mediated & Cholestatic DiseasesПодробнее

Studio at EASL Congress 2024 - Unlocking breakthroughs: Pioneering drug development for ALD&MetALD 1Подробнее

Episode 2 - Podcast from EASL Congress 2024: Key Breakthroughs in the Treatment of Primary Biliar...Подробнее

Discussing Key Clinical Decisions in Managing Primary Biliary CholangitisПодробнее

Primary Biliary Cholangitis: Targeting New Treatment GoalsПодробнее

EASL Studio S07E02 - What does the future management of PBC look like?Подробнее

Update in PBC - Dr Jess DysonПодробнее

EASL Congress 2024 - Wrap up on Cirrhosis & ComplicationsПодробнее

EASL Studio S6E15 Promo - What‘s hot in viral hepatitis in 2024?Подробнее

Exploring Data on Emerging Treatments for Primary Biliary CholangitisПодробнее

Elafibranor for previously treated primary biliary cholangitisПодробнее

EASL Studio at EASL Congress 2024 - New therapeutic options and remaining challenges in PBCПодробнее

EASL Congress 2024 - Wrap up on Liver TumoursПодробнее